Literature DB >> 762212

Gas chromatographic determination of nifedipine and one of its metabolites using electron capture detection.

P Jakobsen, O Lederballe Pedersen, E Mikkelsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 762212     DOI: 10.1016/s0378-4347(00)82066-6

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  19 in total

1.  Pharmacokinetics of nifedipine derived from a new retard tablet formulation.

Authors:  A Avgerinos; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

3.  Relationship between the antihypertensive effect and steady-state plasma concentration of nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.

Authors:  O Lederballe Pedersen; C K Christensen; E Mikkelsen; K D Rämsch
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

4.  Electrochemical and spectroelectrochemical behavior of the main photodegradation product of nifedipine: the nitrosopyridine derivative.

Authors:  L J Núñez-Vergara; S Bollo; J Fuentealba; J C Sturm; J A Squella
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

5.  Haemodialysis does not affect the pharmacokinetics of nifedipine.

Authors:  H Martre; R Sari; A M Taburet; C Jacobs; E Singlas
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

6.  Nifedipine: kinetics and dynamics after single oral doses.

Authors:  H R Ochs; K D Rämsch; B Verburg-Ochs; D J Greenblatt; J Gerloff
Journal:  Klin Wochenschr       Date:  1984-05-02

7.  Dose response and length of action of nifedipine capsules and tablets in patients with essential hypertension: a randomised crossover study.

Authors:  F P Cappuccio; N D Markandu; F A Tucker; G A MacGregor
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 8.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

9.  Nifedipine serum concentration; effects upon blood pressure and heart rate in normotensive volunteers.

Authors:  T Nakashima; M Inoki; Y Nakanishi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

Review 10.  Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.

Authors:  H Echizen; M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.